
|Articles|October 1, 2004
Minocycline shows promise as safe neuroprotective agent
Tel Hashomer, Israel-Results of preclinical studies suggest that minocycline has potential utility as a neuroprotective agent in the management of optic nerve diseases, said Hani Levkovitch-Verbin, MD.
Advertisement
Newsletter
Don’t miss out—get Ophthalmology Times updates on the latest clinical advancements and expert interviews, straight to your inbox.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Ophthalmology Times - Clinical Insights for Eye Specialists
1
FDA approves carbachol–brimonidine eye drop for presbyopia following phase 3 BRIO trials
2
MacTel Decoded: Rethinking Conventional Approaches with Novel Neuroprotective Strategies
3
Inner plexiform layer substrata: Possible biomarker of retinal health
4
Study finds artificial tear viscosity and shear-thinning behavior vary by formulation
5



























